This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Kabushiki Kaisha Yakult Honsha, Keio University. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Shinjuku-ku, JP (2014)
- Tokyo, JP (2015 - 2016)
Company Filing History:
3 out of 215 
3 out of 360 
Years Active: 2014-2016
Title: Sayo Suzuki: Innovator in Cancer Therapeutics
Introduction
Sayo Suzuki is a prominent inventor based in Tokyo, Japan, known for her significant contributions to cancer research and therapy. With a total of three patents to her name, she has made strides in developing methods for determining sensitivity to anticancer agents.
Latest Patents
Her latest patents include a method for determining sensitivity to an anticancer agent, which aims to provide a marker for assessing a patient's response to treatment. This innovative marker is formed from specific proteins detected at various mass-to-charge ratios using a mass spectrometer. Another patent focuses on a method that distinguishes therapeutic responses in individual patients, utilizing calcium-binding proteins such as S100A7, S100A8, or S100A10.
Career Highlights
Sayo Suzuki has worked with esteemed institutions, including Keio University and Yakult Honsha Co., Ltd. Her research has been pivotal in advancing cancer therapies and improving patient outcomes.
Collaborations
She has collaborated with notable colleagues, including Yusuke Tanigawara and Shinji Sugimoto, contributing to her innovative work in the field.
Conclusion
Sayo Suzuki's work exemplifies the intersection of innovation and healthcare, particularly in cancer treatment. Her patents reflect a commitment to improving patient care through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile